Affimed NV (AFMD.OQ)
21 Mar 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|2007||Chairman of the Supervisory Board|
|2011||Chief Executive Officer, Member of the Management Board|
|Chief Financial Officer, Member of the Management Board|
|Chief Operating Officer, Member of the Management Board, Interim Chief Medical Officer|
|2015||Chief Scientific Officer, Member of the Management Board|
- BRIEF-Affimed Announces Proposed Public Offering Of Common Stock
- BRIEF-Affimed Reports New Data For AFM13 From Two Separate Clinical Trials
- BRIEF-Affimed presents data from Phase 1B combination study of AFM13 with pembrolizumab at Ash
- BRIEF-Affimed reports Q3 loss per share EUR 0.18
- BRIEF-Affimed announces Q3 financial results and corporate update conference call